Quartet Lead and Resynchronization Therapy Options
QUARTO
QUARTET LEAD AND RESYNCHRONIZATION THERAPY OPTIONS To Investigate the Stimulatory Possibilities Offered by the Different Configurations Available for the Quartet Lead and Their Effect on Haemodynamic and Clinical Response.
1 other identifier
interventional
51
1 country
1
Brief Summary
The purpose of this Clinical Trial is to determine the percentage of patients whose hemodynamic response improves with the different configurations offered by the new Quartet® left ventricular lead, as a result of its four electrodes, with respect to the configurations offered by a standard bipolar lead. Furthermore, the optimal stimulation configuration will be determined from a comparison with traditional configurations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 heart-failure
Started Jan 2011
Shorter than P25 for phase_4 heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 3, 2011
CompletedFirst Posted
Study publicly available on registry
February 15, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedResults Posted
Study results publicly available
March 6, 2015
CompletedFebruary 20, 2019
February 1, 2019
1.2 years
February 3, 2011
June 6, 2014
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Patients Whose Cardiac Output (CO) Value in Acute, as Measured Echocardiographically, Improves With the Different Stimulation Vectors Offered by the Quartet® Left Ventricular Electrode.
Enrollment visit (in the seven days after implantation of the device)
Secondary Outcomes (10)
Percent Difference Between the Best CO From Non-traditional Vectors and Best CO From Traditional Vectors
At enrollment
Cardiac Output (CO) With Different Configurations at Enrollment
Enrollment visit (in the seven days after implantation of the device)
Capture Threshold
Enrollment visit (in the seven days after implantation of the device)
Capture Threshold
6 months post-implant
Number of Vectors With Phrenic Nerve Stimulation (PNS)
Enrollment visit (in the seven days after implantation of the device)
- +5 more secondary outcomes
Study Arms (1)
CRT therapy
NO INTERVENTIONCardiac Resynchronization Therapy Defibrillator (CRT-D)
Interventions
Cardiac Resynchronization Therapy Defibrillator
Eligibility Criteria
You may qualify if:
- Patients with a Cardiac resynchronization Therapy Defibrillator device (CRT-D) and a Quartet® quadripolar electrode from St Jude Medical (used in "Single Site Pacing" mode) implanted in the left ventricle.
- Patients who have provided written informed consent
- Patients who are in sinus rhythm.
- Patients older than 18 years of age.
You may not qualify if:
- Patients in atrial fibrillation at the time of the echocardiographic study of the enrollment visit.
- Patients with valvular disease.
- Patients in functional class New York Heart Association (NYHA) IV
- Patients for whom echocardiography images suitable for determining the cardiac output cannot be obtained.
- Patients whose device has been changed/upgraded.
- Pregnant patients.
- Patients who are unable to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clínico Universitario Virgen de la Victoria
Málaga, 29010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Javier Alzueta
- Organization
- Hospital Universitario Virgen de la Victoria
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Francisco Javier Alzueta Rodríguez, PhD
Hospital Clínico Universitario Virgen de la Victoria
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2011
First Posted
February 15, 2011
Study Start
January 1, 2011
Primary Completion
April 1, 2012
Study Completion
September 1, 2012
Last Updated
February 20, 2019
Results First Posted
March 6, 2015
Record last verified: 2019-02